StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
AGM/EGMJul 10, 2026, 04:33 PM

Nexalin Technology to Vote on Reverse Stock Split, Equity Plan

AI Summary

Nexalin Technology, Inc. has filed a definitive proxy statement for its Annual Meeting of Stockholders scheduled for August 11, 2026. Key proposals for stockholder consideration include the election of five directors, approval of a 2026 Equity Incentive Plan, and authorization for a reverse stock split ranging from 1-for-2 to 1-for-100, with an aggregate limit of 1-for-250. Additionally, stockholders will vote on authorizing 10 million shares of preferred stock, providing for officer exculpation, and ratifying the appointment of independent auditors.

Key Highlights

  • Annual Meeting of Stockholders to be held virtually on August 11, 2026, at 10:00 a.m. EST.
  • Stockholders will vote on the election of five directors.
  • Proposal to approve the Nexalin Technology, Inc. 2026 Equity Incentive Plan.
  • Proposal to approve a reverse stock split at a ratio between 1-for-2 and 1-for-100, up to 1-for-250.
  • Proposal to authorize 10 million shares of preferred stock.
  • Proposal to amend the Certificate of Incorporation to provide for officer exculpation.
  • Ratification of CBIZ CPAs P.C. as independent auditors for fiscal year 2026.
  • Record date for voting eligibility is July 6, 2026.